Biofil Chemicals & Pharmaceuticals (BOM:524396) Beta: 1.5123 (As of Jun. 29, 2026)


BOM:524396 Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
65 GF Score
Price ₹35.98
GF Value ₹41.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals Beta?

Biofil Chemicals & Pharmaceuticals BOM:524396 65 Beta is 1.5123 as of Jun. 29, 2026. GuruFocus rates BOM:524396 with a GF Score™ of 65/100 and a GF Value™ of ₹41.83 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Biofil Chemicals & Pharmaceuticals's Beta is 1.5123.


Biofil Chemicals & Pharmaceuticals  (BOM:524396) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Biofil Chemicals & Pharmaceuticals Beta Related Terms


Biofil Chemicals & Pharmaceuticals Beta Historical Data

* Premium members only.

The historical data trend for Biofil Chemicals & Pharmaceuticals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals Beta Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.80 3.70 0.43 1.28 1.33

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.31 1.48 1.33 1.33

BOM:524396 vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Beta distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Beta falls into.


BOM:524396
65GF Score
Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofil Chemicals & Pharmaceuticals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5123 mean?
Biofil Chemicals & Pharmaceuticals (BOM:524396) has a Beta of 1.5123 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Biofil Chemicals & Pharmaceuticals and its competitors.
Is Biofil Chemicals & Pharmaceuticals' Beta too high?
Biofil Chemicals & Pharmaceuticals' current Beta is 1.5123. Overall, Biofil Chemicals & Pharmaceuticals has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biofil Chemicals & Pharmaceuticals' Beta compare to ZTS and UTHR?
Biofil Chemicals & Pharmaceuticals' Beta of 1.5123 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Biofil Chemicals & Pharmaceuticals and its competitors. Biofil Chemicals & Pharmaceuticals's current Beta is 1.5123. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofil Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals (BOM:524396) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹41.83, compared to a current price of ₹35.98 — trading 14% below its estimated fair value. The current Beta is 1.5123. Biofil Chemicals & Pharmaceuticals' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Biofil Chemicals & Pharmaceuticals (BOM:524396), the current Beta is 1.5123 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofil Chemicals & Pharmaceuticals (BOM:524396) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹35.98 is trading 14% below its estimated GF Value™ of ₹41.83. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:524396:

  • Beta: 1.5123
  • GF Value™: ₹41.83 vs. price of ₹35.98 (14% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the BOM:524396 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges BIOFILCHEM:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
65GF Score

Get the complete analysis for BOM:524396

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.98
Price
₹41.83
GF Value